-
Most Recent
Search Results
240 results for myx
How Rare Earths, Inflation, and Tech Will Drive Markets Higher in 2025
My motto remains: AI with AI. That means focusing your portfolio squarely on companies directly enabling the AI revolution – semiconductors, energy infrastructure, battery makers,…
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks
During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to…
Unlock AI Profits With This New “Master Key”
“Don’t be afraid of artificial intelligence – invest in it!” That was my advice to readers in the September 27, 2019, issue of my Market…
Three Stocks to Consider Today
If you’re not looking at every stock in your portfolio through the lens of AI, you’re missing the big picture. And in this market, that’s…
Louis Navellier’s Best Stock Picks – on Steroids
The markets can sometimes seem unpredictable, but what if there were patterns hidden in plain sight? To help identify these hidden patterns, legendary growth investor…
Breaking: The Pentagon Just Sent My Trump AI Day Pick Up By 48%
Just this morning, the Pentagon announced a $400 million investment into MP Materials, instantly positioning the company as a strategic national security play – and…
How to “Buy Amazon Like It’s 2005″… in 2025
In today’s Smart Money, I’ll detail why many of the companies poised to potentially fail will be household names you are already familiar with –…
C3.AI Generates Big Growth, But Isn’t a Buy Yet
AI stock is worth watching though, as it powers technological innovation. A calmer market or higher earnings could make it a buy.
GEVO Lands a Big Client But Isn’t a Buy Yet
Delta is working with Gevo for a greener tomorrow, but until the agreement meaningfully boosts its financials, GEVO stock isn’t quite a buy.
C3.AI Just Added an Important New Board Member
The latest addition to the board is positive news for AI stock. However, earnings still need to improve before investors pick up shares.
IonQ Is an Interesting Company But Not a Buy Now
IONQ stock has had a wild ride since going public in 2021. It has fascinating tech but it’s better to wait and see on this…
Clover Health’s Earnings Losses Make It One to Avoid for Now
CLOV stock should not be bought until it has positive earnings. The company has good growth to report but needs earnings to lower the risk.
Pump the Breaks on NIO Stock Until the Risks Subside
NIO stock has already exponentially advanced and it has too much risk at these prices. Here’s why you should avoid it for now.
8 – 10 of 240 results
